Papers associated with nervous system (and grin1)

Limit to papers also referencing gene:
Show all nervous system papers

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

	Male-transmitted transgenerational effects of the herbicide linuron on DNA methylation profiles in Xenopus tropicalis brain and testis., Roza M., Sci Total Environ. May 1, 2024; 923 170949.
	Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.
	Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy., Xu Y., Ann Clin Transl Neurol. July 1, 2021; 8 (7): 1480-1494.
	Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders., Tang W., Neuropharmacology. October 15, 2020; 177 108247.
	Postsynaptic and Presynaptic NMDARs Have Distinct Roles in Visual Circuit Development., Kesner P., Cell Rep. July 28, 2020; 32 (4): 107955.
	De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases., Li J., Hum Mutat. December 1, 2019; 40 (12): 2393-2413.
	An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups., Perszyk R., Elife. May 24, 2018; 7
	All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class., Castillo-Gómez E., Mol Psychiatry. December 1, 2017; 22 (12): 1776-1784.
	A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons., Kostakis E., J Neurochem. November 1, 2011; 119 (3): 486-96.
	The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit., Zhang Y, Zhang Y., J Neurosci. June 2, 2010; 30 (22): 7575-86.
	Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists., Hansen KB., J Pharmacol Exp Ther. June 1, 2010; 333 (3): 650-62.
	Regulation of radial glial motility by visual experience., Tremblay M., J Neurosci. November 11, 2009; 29 (45): 14066-76.
	Molecular and functional characterization of Xenopus laevis N-methyl-d-aspartate receptors., Schmidt C., Mol Cell Neurosci. October 1, 2009; 42 (2): 116-27.
	Cloning and Phylogenetic Analysis of NMDA Receptor Subunits NR1, NR2A and NR2B in Xenopus laevis Tadpoles., Ewald RC., Front Mol Neurosci. September 11, 2009; 2 4.
	The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors., Yuan H., J Biol Chem. May 8, 2009; 284 (19): 12862-73.
	Differential effect of high pressure on NMDA receptor currents in Xenopus laevis oocytes., Mor A., Diving Hyperb Med. December 1, 2008; 38 (4): 194-6.
	Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function., Samson AL., J Neurochem. November 1, 2008; 107 (4): 1091-101.
	The NR1 M3 domain mediates allosteric coupling in the N-methyl-D-aspartate receptor., Blanke ML., Mol Pharmacol. August 1, 2008; 74 (2): 454-65.
	Constitutive activation of the N-methyl-D-aspartate receptor via cleft-spanning disulfide bonds., Blanke ML., J Biol Chem. August 1, 2008; 283 (31): 21519-29.
	Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes., Chen PE., J Physiol. January 1, 2008; 586 (1): 227-45.
	Molecular and functional studies of tilapia (Oreochromis mossambicus) NMDA receptor NR1 subunits., Tzeng DW., Comp Biochem Physiol B Biochem Mol Biol. March 1, 2007; 146 (3): 402-11.
	Activity-dependent neurotransmitter-receptor matching at the neuromuscular junction., Borodinsky LN., Proc Natl Acad Sci U S A. January 2, 2007; 104 (1): 335-40.
	RNA interference of Xenopus NMDAR NR1 in vitro and in vivo., Miskevich F., J Neurosci Methods. April 15, 2006; 152 (1-2): 65-73.
	Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity., Woods AS., J Proteome Res. April 1, 2006; 5 (4): 1017-23.
	Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner., Masuko T., Neurosci Lett. November 16, 2004; 371 (1): 30-3.
	Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids., Malayev A., Br J Pharmacol. February 1, 2002; 135 (4): 901-9.
	The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801., Rammes G., Neuropharmacology. May 1, 2001; 40 (6): 749-60.
	Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes., Cruz SL., Br J Pharmacol. December 1, 2000; 131 (7): 1303-8.
	Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors., Low CM., Proc Natl Acad Sci U S A. September 26, 2000; 97 (20): 11062-7.
	NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A., Goebel DJ., Brain Res Mol Brain Res. June 8, 1999; 69 (2): 164-70.
	Investigation by ion channel domain transplantation of rat glutamate receptor subunits, orphan receptors and a putative NMDA receptor subunit., Villmann C., Eur J Neurosci. May 1, 1999; 11 (5): 1765-78.
	Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors., Honer M., J Biol Chem. May 1, 1998; 273 (18): 11158-63.
	Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+., Wollmuth LP., J Physiol. January 1, 1998; 506 ( Pt 1) 13-32.
	An active-site histidine of NR1/2C mediates voltage-independent inhibition by zinc., Gray AT., Brain Res Mol Brain Res. December 1, 1997; 52 (1): 157-61.
	Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids., Park-Chung M., Mol Pharmacol. December 1, 1997; 52 (6): 1113-23.
	Xenopus oocytes express a unitary glutamate receptor endogenously., Soloviev MM., J Mol Biol. October 17, 1997; 273 (1): 14-8.
	Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes., Supplisson S., J Neurosci. June 15, 1997; 17 (12): 4580-90.
	Functional expression of a recombinant unitary glutamate receptor from Xenopus, which contains N-methyl-D-aspartate (NMDA) and non-NMDA receptor subunits., Soloviev MM., J Biol Chem. December 20, 1996; 271 (51): 32572-9.
	Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol., Ilyin VI., Mol Pharmacol. December 1, 1996; 50 (6): 1541-50.
	Polyamine spider toxins and mammalian N-methyl-D-aspartate receptors. Structural basis for channel blocking and binding of argiotoxin636., Raditsch M., Eur J Biochem. September 1, 1996; 240 (2): 416-26.
	Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors., Zhong J., Mol Pharmacol. September 1, 1996; 50 (3): 631-8.
	Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes., Buller AL., Mol Pharmacol. October 1, 1995; 48 (4): 717-23.
	Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain., Sucher NJ., J Neurosci. October 1, 1995; 15 (10): 6509-20.
	Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines., Traynelis SF., Science. May 12, 1995; 268 (5212): 873-6.
	Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site., Grimwood S., J Neurochem. February 1, 1995; 64 (2): 525-30.
	Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine., Williams K., Mol Pharmacol. September 1, 1994; 46 (3): 531-41.
	The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition., Buller AL., J Neurosci. September 1, 1994; 14 (9): 5471-84.
	Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins., Kuryatov A., Neuron. June 1, 1994; 12 (6): 1291-300.
	Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits., Williams K., Mol Pharmacol. May 1, 1994; 45 (5): 803-9.
	Effects of nitroprusside and redox reagents on NMDA receptors expressed in Xenopus oocytes., Omerovic A., Brain Res Mol Brain Res. March 1, 1994; 22 (1-4): 89-96.

???pagination.result.page??? 1 2 ???pagination.result.next???